Síndrome de secreción inadecuada de hormona antidiurética en paciente con linfoma difuso de células grandes B

Navarro-Almenzar, Begoña; Cabañas Perianes, Valentín.
Med. clín (Ed. impr.) ; 154(11): 473-473, jun. 2020. ilus
Artículo en Español | IBECS (España) | ID: ibc-195548

Documentos relacionados

  1. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
  2. Dual epigenetic agents plus rituximab-gemcitabine-oxaliplatin as salvage treatment in relapsed/refractory diffuse large B-cell lymphoma patients failure of salvage chemotherapy.
  3. Recurrent splice site mutations affect key diffuse large B-cell lymphoma genes.
  4. Identification of the shared gene signatures and molecular pathways in systemic lupus erythematosus and diffuse large B-cell lymphoma.
  5. Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group.
  6. A coordinated strategy for a simple, pragmatic approach to the early identification of the ultra-high-risk patient with diffuse large B-cell lymphoma.
  7. Clinical boundaries in adult cases of large B cell lymphoma with IRF4 rearrangement.
  8. The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa.
  9. Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma.
  10. Tissue-Matched IgH Gene Rearrangement of Circulating Tumor DNA Shows Significant Value in Predicting the Progression of Diffuse Large B Cell Lymphoma.